Skip to content

InTerlaboratory Evaluation of a GastroIntestinal Activity ErgoMeterTest in Non-intense Trained PersOns

InTerlaboratory Evaluation of a GastroIntestinal Activity ErgoMeterTest in Non-intense Trained PersOns - TEMPO! 2.0

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45536
Enrollment
16
Registered
2017-03-09
Start date
2017-05-22
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal activity gastrointestinal function

Interventions

-Ingestion of a multisugar and glutamin/alanin solution -Exercise with different load
Ergometertest
Gastro-intestinal activity
Healthy men
Interlaboratory evaluation

Sponsors

Hogeschool Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: -Male -Generally healthy -Recreational athlete with at least two years of cycling experience of at least twice a week -18-35 years old -Meeting criteria of valid max-test -Body mass index (BMI) 18.5-25 kg/m2 -Veins suitable for blood sampling at inspection

Exclusion criteria

Exclusion criteria: -Diagnosed with an immune disease such as diabetes, coeliac disease, rheumatoid arthritis -Diagnosed with an gastro-intestinal disease such as Crohn*s disease, colitis ulcerosa, irritable bowel syndrome -abnormal ECG, e.g. an aberrant QT time -Allergies -Smoking -Use of hard drugs -Use of pre- and probiotics -(Chronic) use of specific medicines: *chronic use of NSAIDs: aspirin, ibuprofen, corticosteroids *chronic use of antidepressiva, antacids (Rennie), benzodiazepines (Valium) * drugs against abdominal pain and cramping (e.g.buscopan, imodium), -Participation in other scientific studies within 1 month before the preliminary testing -Blood donation six weeks prior to the start of the study

Design outcomes

Primary

MeasureTime frame
The relative changes in blood of iFABP (intestinal function), lymphocytes, leukocytes, monocytes (immune response).

Secondary

MeasureTime frame
The relative changes in blood, urine and saliva of several markers of intestinal function, immune responsiveness and general physiology: e.g. cytokines, RNA-profiling of bloodcells, cortisol, aminoacids, sugars.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)